Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Galectin Therapeutic (GALT)

4.22 0.03 (0.72%)

02-22 16:00

Open:

4.21

Pre. Close:

4.19

High:

4.33

Low:

4.101

Volume:

119,366

Market Cap:

153M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.332 - 4.354

4.354 - 4.375

Low:

4.051 - 4.073

4.073 - 4.095

Close:

4.185 - 4.219

4.219 - 4.254

Technical analysis  (as of: 2018-02-22 5:01:16 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 6.07     One year: 7.14

Support:

Support1: 3.71    Support2: 3.09

Resistance:

Resistance1: 5.19    Resistance2: 6.11

Pivot:

4.17

Moving Averages:

MA(5): 4.21     MA(20): 4.38

MA(100): 3.32     MA(250): 2.68

MACD:

MACD(12,26): -0.08     Signal(12,26,9): -0.03

%K %D:

%K(14,3): 43.13     %D(3): 37.32

RSI:

RSI(14): 47.96

52-Week:

High: 6.74  Low: 1.28  Change(%): 122.1

Average Vol(K):

3-Month: 105344  10-Days 38943

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
GALT has closed below upper band by 41.9%. Bollinger Bands are 56% narrower than normal. The narrow width of the bands suggests low volatility as compared to GALT's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 15 Feb 2018 19:07:30 GMT
Update On Galectin Therapeutics' Potential Entry Into Cancer Market

Tue, 06 Feb 2018 14:15:00 GMT
Galectin Therapeutics to Present at BIO CEO & Investor Conference

Tue, 20 Feb 2018 12:56:15 GMT
NASH Pathogenesis: Better Understanding And A Look At Galectin

Thu, 25 Jan 2018 13:30:00 GMT
Galectin Therapeutics Granted Patents in China and Japan that Support NASH and ...

Mon, 29 Jan 2018 14:26:15 GMT
Galectin Therapeutics: Lackluster Trial Results, Bad Credit Line Somehow Jump ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

35.64

Shares Float (M)

28.02

% Held by Insiders

% Held by Institutions

8.40

Shares Short (K)

988

Shares Short Prior Month (K)

1040

Stock Financials

EPS

-0.550

EPS Est. Current Year

-0.530

EPS Est. Next Year

-0.520

EPS Est. Next Quarter

-0.130

Forward EPS

-0.480

Book Value (p.s.)

103.910

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-164.0

Return on Equity (ttm)

1597.3

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.518

Qtrly Earnings Growth

Operating Cash Flow (M)

-16.85

Levered Free Cash Flow (M)

-10.50

atoplab.com

Valuation

P/E

-7.67

P/E Growth Ratio

0.01

P/BV

0.04

P/S

P/CF

-8.93

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2012-03-23

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.